|
ATE482747T1
(de)
*
|
2003-04-11 |
2010-10-15 |
High Point Pharmaceuticals Llc |
Neue amide derivate und deren pharmazeutische verwendungen
|
|
EP1862181A3
(en)
*
|
2003-04-11 |
2010-09-15 |
High Point Pharmaceuticals, LLC |
New pyrazolo[1,5-a] pyrimidine derivatives and pharmaceutical use thereof
|
|
AR046078A1
(es)
|
2003-08-06 |
2005-11-23 |
Senomyx Inc |
Nuevos sabores, modificadores de sabores, sustancias gustativas, mejoradores de gusto, sustancias gustativas y/o mejoradoras del gusto umani o dulce y uso de los mismos.
|
|
EP1653949A4
(en)
|
2003-08-07 |
2009-04-22 |
Merck & Co Inc |
PYRAZOL CARBOXAMIDE AS AN INHIBITOR OF 11-BETA-HYDROXYSTEROID DEHYDROGENASE-1
|
|
GB0326029D0
(en)
*
|
2003-11-07 |
2003-12-10 |
Astrazeneca Ab |
Chemical compounds
|
|
JP4638355B2
(ja)
*
|
2003-12-26 |
2011-02-23 |
協和発酵キリン株式会社 |
チアゾール誘導体
|
|
AU2004312530A1
(en)
|
2003-12-29 |
2005-07-21 |
Sepracor Inc. |
Pyrrole and pyrazole DAAO inhibitors
|
|
US7880001B2
(en)
|
2004-04-29 |
2011-02-01 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
US8415354B2
(en)
|
2004-04-29 |
2013-04-09 |
Abbott Laboratories |
Methods of use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
US20100222316A1
(en)
|
2004-04-29 |
2010-09-02 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
TWI350168B
(en)
|
2004-05-07 |
2011-10-11 |
Incyte Corp |
Amido compounds and their use as pharmaceuticals
|
|
AU2005240784C1
(en)
|
2004-05-07 |
2011-12-22 |
Janssen Pharmaceutica N.V. |
Pyrrolidin-2-one and piperidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
US20050288317A1
(en)
*
|
2004-06-24 |
2005-12-29 |
Wenqing Yao |
Amido compounds and their use as pharmaceuticals
|
|
US8071624B2
(en)
|
2004-06-24 |
2011-12-06 |
Incyte Corporation |
N-substituted piperidines and their use as pharmaceuticals
|
|
JP2008509146A
(ja)
|
2004-08-06 |
2008-03-27 |
メルク エンド カムパニー インコーポレーテッド |
１１−ベータ−ヒドロキシステロイドデヒドロゲナーゼ−１の阻害剤としてのスルホニル化合物
|
|
CA2576850C
(en)
|
2004-08-30 |
2013-06-25 |
Janssen Pharmaceutica N.V. |
Tricyclic lactam derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors
|
|
CN101300005B
(zh)
*
|
2004-08-30 |
2013-05-01 |
詹森药业有限公司 |
作为11-β羟类固醇脱氢酶抑制剂的N-2金刚烷基-2-苯氧基-乙酰胺衍生物
|
|
DE602005017159D1
(de)
|
2004-08-30 |
2009-11-26 |
Janssen Pharmaceutica Nv |
Oxysteroid-dehydrogenase-inhibitoren
|
|
CN101014578B
(zh)
|
2004-09-16 |
2011-01-19 |
安斯泰来制药有限公司 |
三唑衍生物或其盐
|
|
EP1802623A1
(en)
*
|
2004-10-12 |
2007-07-04 |
Novo Nordisk A/S |
11beta-hydroxysteroid dehydrogenase type 1 active spiro compounds
|
|
AU2005298986A1
(en)
*
|
2004-10-27 |
2006-05-04 |
F. Hoffmann-La Roche Ag |
New indole or benzimidazole derivatives
|
|
EP1807080A1
(en)
*
|
2004-10-29 |
2007-07-18 |
AstraZeneca AB |
Use of unsaturated quionoline or naphtalene derivatives as medicaments
|
|
ES2547724T3
(es)
*
|
2004-11-10 |
2015-10-08 |
Incyte Corporation |
Compuestos de lactama y su uso como productos farmacéuticos
|
|
US8110581B2
(en)
|
2004-11-10 |
2012-02-07 |
Incyte Corporation |
Lactam compounds and their use as pharmaceuticals
|
|
CN101103016A
(zh)
*
|
2004-11-18 |
2008-01-09 |
因塞特公司 |
11-β羟基类固醇脱氢酶1型抑制剂及其使用方法
|
|
MX2007008238A
(es)
|
2005-01-05 |
2007-08-17 |
Abbott Lab |
Derivados de adamantilo como inhibidores de la enzima 11-beta-hidroxiesteroide deshidrogenasa tipo 1.
|
|
CN101142172A
(zh)
|
2005-01-05 |
2008-03-12 |
艾博特公司 |
11-β-羟甾类脱氢酶1型酶的抑制剂
|
|
US8198331B2
(en)
|
2005-01-05 |
2012-06-12 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
US20090192198A1
(en)
|
2005-01-05 |
2009-07-30 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase type 1 enzyme
|
|
FR2880887B1
(fr)
*
|
2005-01-14 |
2009-01-30 |
Merck Sante Soc Par Actions Si |
Derives d'hydroxyphenols, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
|
|
JP4734346B2
(ja)
|
2005-02-04 |
2011-07-27 |
セノミックス インコーポレイテッド |
連結ヘテロアリール部分を含む化合物、ならびに食用組成物のための新規なうまみフレーバー改変剤、味物質および味覚増強剤としての使用
|
|
GB0506133D0
(en)
*
|
2005-03-24 |
2005-05-04 |
Sterix Ltd |
Compound
|
|
EP1866298A2
(en)
*
|
2005-03-31 |
2007-12-19 |
Takeda San Diego, Inc. |
Hydroxysteroid dehydrogenase inhibitors
|
|
EP1928840B1
(en)
*
|
2005-04-05 |
2011-08-10 |
F. Hoffmann-La Roche AG |
1H-Pyrazole-4-carboxamides, their preparation and their use as 11-beta-hydroxysteroid dehydrogenase inhibitors
|
|
US20060235028A1
(en)
*
|
2005-04-14 |
2006-10-19 |
Li James J |
Inhibitors of 11-beta hydroxysteroid dehydrogenase type I
|
|
TW200716576A
(en)
|
2005-06-07 |
2007-05-01 |
Shionogi & Co |
Heterocyclic derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
RU2383539C2
(ru)
*
|
2005-06-08 |
2010-03-10 |
Джапан Тобакко Инк. |
Гетероциклические соединения
|
|
BRPI0611179A2
(pt)
*
|
2005-06-08 |
2010-08-24 |
Japan Tobacco Inc |
compostos heterocÍclicos, inibidor de 11bhsd1, agente farmacÊutico, uso dos referidos compostos, embalagem comercial e composiÇço farmacÊutica
|
|
KR100970294B1
(ko)
*
|
2005-06-08 |
2010-07-15 |
니뽄 다바코 산교 가부시키가이샤 |
복소환 화합물
|
|
TW200715993A
(en)
|
2005-06-15 |
2007-05-01 |
Senomyx Inc |
Bis-aromatic amides and their uses as sweet flavor modifiers, tastants, and taste enhancers
|
|
US7605289B2
(en)
|
2005-06-17 |
2009-10-20 |
Amgen, Inc. |
Benzamide derivatives and uses related thereto
|
|
ES2528451T3
(es)
|
2005-06-17 |
2015-02-10 |
Apogee Biothechnology Corporation |
Inhibidores de esfingosina cinasa
|
|
GB0513702D0
(en)
|
2005-07-04 |
2005-08-10 |
Sterix Ltd |
Compound
|
|
GB0514018D0
(en)
*
|
2005-07-07 |
2005-08-17 |
Ionix Pharmaceuticals Ltd |
Chemical compounds
|
|
JP2009505955A
(ja)
|
2005-07-22 |
2009-02-12 |
アムゲン インコーポレイティッド |
アニリンスルホンアミド誘導体およびそれらの使用
|
|
EP2392571A3
(en)
|
2005-07-29 |
2012-03-14 |
F. Hoffmann-La Roche AG |
Indol-3-yl-carbonyl-piperidin and piperazin derivatives
|
|
DK1910384T3
(da)
*
|
2005-08-04 |
2012-12-17 |
Sirtris Pharmaceuticals Inc |
Imidazo [2,1-b] thiazol-derivater som sirtuinmodulerende forbindelser
|
|
US7622492B2
(en)
|
2005-08-31 |
2009-11-24 |
Hoffmann-La Roche Inc. |
Pyrazolones as inhibitors of 11β-hydroxysteroid dehydrogenase
|
|
GB2429975A
(en)
*
|
2005-09-08 |
2007-03-14 |
Univ Edinburgh |
1,5-substituted-1H-tetrazole 11beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
|
CA2621255A1
(en)
*
|
2005-09-21 |
2007-04-05 |
Incyte Corporation |
Amido compounds and their use as pharmaceuticals
|
|
EA200801243A1
(ru)
*
|
2005-11-01 |
2008-10-30 |
Транстек Фарма |
Фармацевтическое применение замещенных амидов
|
|
KR20080069189A
(ko)
*
|
2005-11-01 |
2008-07-25 |
트랜스테크 파르마, 인크. |
치환된 아미드의 약학적 사용
|
|
US8324265B2
(en)
*
|
2005-11-21 |
2012-12-04 |
Shionogi & Co., Ltd. |
Heterocyclic compounds having type I 11β hydroxysteroid dehydrogenase inhibitory activity
|
|
CA2630492C
(en)
|
2005-12-05 |
2015-04-14 |
Incyte Corporation |
Spiro-lactam compounds
|
|
EP1801098A1
(en)
|
2005-12-16 |
2007-06-27 |
Merck Sante |
2-Adamantylurea derivatives as selective 11B-HSD1 inhibitors
|
|
BRPI0706365A2
(pt)
|
2006-01-06 |
2011-03-22 |
Sepracor Inc |
Cicloalquilaminas como inibidores da recaptação de monoamina
|
|
NZ569608A
(en)
|
2006-01-06 |
2011-09-30 |
Sepracor Inc |
Tetralone-based monoamine reuptake inhibitors
|
|
WO2007084314A2
(en)
|
2006-01-12 |
2007-07-26 |
Incyte Corporation |
MODULATORS OF 11-ß HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
|
|
TW200734313A
(en)
*
|
2006-01-17 |
2007-09-16 |
Astrazeneca Ab |
Piperazines and piperidines as mGluR5 potentiators
|
|
BRPI0710479A2
(pt)
|
2006-01-18 |
2012-08-14 |
Hoffmann La Roche |
composto, processo para sua preparaÇço, composiÇço farmacÊutica, uso de um composto e mÉtodo de tratamento de doenÇa ou desosrdem metabàlica.
|
|
KR20080093123A
(ko)
*
|
2006-02-13 |
2008-10-20 |
에프. 호프만-라 로슈 아게 |
당뇨병 치료용 헤테로바이사이클릭 설폰아마이드 유도체
|
|
JP2009530346A
(ja)
*
|
2006-03-21 |
2009-08-27 |
ハイ ポイント ファーマシューティカルズ，リミティド ライアビリティ カンパニー |
メタボリックシンドロームの治療用のアダマンタン誘導体
|
|
HUE026011T2
(en)
*
|
2006-03-22 |
2016-05-30 |
Hoffmann La Roche |
Pyrazoles as 11-beta-HSD-1
|
|
EP2006286A4
(en)
|
2006-03-30 |
2010-04-07 |
Shionogi & Co |
ISOXAZOLE DERIVATIVE AND ISOTHIAZONE DERIVATIVITY WITH ANTICIPATING EFFECT ON 11 TYPE I BETA HYDROXYSTEROIDDEHYDROGENASE
|
|
DK2816024T3
(en)
|
2006-03-31 |
2017-10-30 |
Sunovion Pharmaceuticals Inc |
CHIRALE AMINER
|
|
US7435833B2
(en)
*
|
2006-04-07 |
2008-10-14 |
Abbott Laboratories |
Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme
|
|
KR20090014347A
(ko)
*
|
2006-04-07 |
2009-02-10 |
하이 포인트 파마슈티칼스, 엘엘씨 |
11β-히드록시스테로이드 탈수소효소 타입 1 활성 화합물
|
|
ES2640453T3
(es)
|
2006-04-21 |
2017-11-03 |
Senomyx, Inc. |
Procesos para preparar composiciones saborizantes sólidas
|
|
JP2009535420A
(ja)
|
2006-05-01 |
2009-10-01 |
インサイト・コーポレイション |
１１−βヒドロキシルステロイドデヒドロゲナーゼタイプ１のモジュレーターとしてのテトラ置換ウレア
|
|
PE20080251A1
(es)
|
2006-05-04 |
2008-04-25 |
Boehringer Ingelheim Int |
Usos de inhibidores de dpp iv
|
|
EP2018378A2
(en)
|
2006-05-17 |
2009-01-28 |
Incyte Corporation |
Heterocyclic inhibitors of 11-b hydroxyl steroid dehydrogenase type i and methods of using the same
|
|
TW200808695A
(en)
|
2006-06-08 |
2008-02-16 |
Amgen Inc |
Benzamide derivatives and uses related thereto
|
|
ATE476418T1
(de)
|
2006-06-08 |
2010-08-15 |
Amgen Inc |
Benzamidderivate und assoziierte verwendungen
|
|
EP2038255A2
(en)
*
|
2006-06-16 |
2009-03-25 |
High Point Pharmaceuticals, LLC |
Pharmaceutical use of substituted piperidine carboxamides
|
|
FR2902791B1
(fr)
*
|
2006-06-27 |
2008-08-22 |
Sanofi Aventis Sa |
Derives d'urees de tropane,leur preparation et leur application en therapeutique
|
|
TW200811158A
(en)
|
2006-06-27 |
2008-03-01 |
Sanofi Aventis |
Piperidine or pyrrolidine urea derivatives, their preparation and their therapeutic application
|
|
TW200811170A
(en)
|
2006-06-27 |
2008-03-01 |
Sanofi Aventis |
Urea derivatives of tropane, their preparation and their therapeutic application
|
|
US7884124B2
(en)
|
2006-06-30 |
2011-02-08 |
Sepracor Inc. |
Fluoro-substituted inhibitors of D-amino acid oxidase
|
|
WO2008006702A1
(en)
*
|
2006-07-13 |
2008-01-17 |
High Point Pharmaceuticals, Llc. |
11beta-hydroxysteroid dehydrogenase type 1 active compounds
|
|
EP1878721A1
(en)
*
|
2006-07-13 |
2008-01-16 |
Novo Nordisk A/S |
4-Piperidylbenzamides as 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
|
EP2061767B1
(de)
|
2006-08-08 |
2014-12-17 |
Sanofi |
Arylaminoaryl-alkyl-substituierte Imidazolidin-2,4-dione, Verfahren zu ihrer Herstellung, diese Verbindungen enthaltende Arzneimittel und ihre Verwendung
|
|
US7727978B2
(en)
*
|
2006-08-24 |
2010-06-01 |
Bristol-Myers Squibb Company |
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
MX2009002019A
(es)
|
2006-08-24 |
2009-03-09 |
Novartis Ag |
Derivados de 2-(pirazin-2-il)-tiazol y 2-(1h-pirazol-3-il)-tiazol asi como compuestos relacionados como inhibidores de la estearoil-coa-desaturasa (scd) para el tratamiento de trastornos metabolicos, cardiovasculares, y otros.
|
|
CA2662574A1
(en)
|
2006-09-22 |
2008-03-27 |
Novartis Ag |
Heterocyclic organic compounds
|
|
AU2007340273B2
(en)
|
2006-10-17 |
2012-08-30 |
Rutgers, The State University Of New Jersey |
N-substituted monomers and polymers
|
|
TW200827346A
(en)
*
|
2006-11-03 |
2008-07-01 |
Astrazeneca Ab |
Chemical compounds
|
|
US8563573B2
(en)
|
2007-11-02 |
2013-10-22 |
Vertex Pharmaceuticals Incorporated |
Azaindole derivatives as CFTR modulators
|
|
DE602007006990D1
(de)
*
|
2006-12-07 |
2010-07-15 |
Hoffmann La Roche |
Spiropiperidinderivate als antagonisten des via-rezeptors
|
|
WO2008069518A1
(en)
*
|
2006-12-08 |
2008-06-12 |
Amorepacific Corporation |
Pharmaceutical composition for controlling the function of spihngosylphosphorylcholine
|
|
WO2008074835A1
(en)
|
2006-12-20 |
2008-06-26 |
Novartis Ag |
2-substituted 5-membered heterocycles as scd inhibitors
|
|
EP1935420A1
(en)
|
2006-12-21 |
2008-06-25 |
Merck Sante |
2-Adamantyl-butyramide derivatives as selective 11beta-HSD1 inhibitors
|
|
BRPI0721138A2
(pt)
*
|
2006-12-22 |
2014-04-01 |
Hoffmann La Roche |
Derivados de espiro-piperidina
|
|
CA2673586A1
(en)
|
2006-12-26 |
2008-07-24 |
Amgen Inc. |
N-cyclohexyl benzamides and benzeneacetamides as inhibitors of 11-beta-hydroxysteroid dehydrogenases
|
|
US7902252B2
(en)
|
2007-01-18 |
2011-03-08 |
Sepracor, Inc. |
Inhibitors of D-amino acid oxidase
|
|
AU2011232811B2
(en)
*
|
2007-02-12 |
2012-05-31 |
Astrazeneca Ab |
Pyrazole derivatives as 11-beta-HSD1 inhibitors
|
|
TW200836719A
(en)
*
|
2007-02-12 |
2008-09-16 |
Astrazeneca Ab |
Chemical compounds
|
|
EP2125704A1
(en)
*
|
2007-02-23 |
2009-12-02 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2150526B1
(en)
*
|
2007-02-23 |
2017-09-20 |
vTv Therapeutics LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
WO2008101885A1
(en)
*
|
2007-02-23 |
2008-08-28 |
High Point Pharmaceuticals, Llc |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
EP2129652A2
(en)
*
|
2007-02-23 |
2009-12-09 |
High Point Pharmaceuticals, LLC |
N-adamantyl benzamides as inhibitors of 11-beta-hydroxysteroid dehydrogenase
|
|
WO2008110196A1
(en)
|
2007-03-09 |
2008-09-18 |
High Point Pharmaceuticals, Llc |
Indole- and benzimidazole amides as hydroxysteroid dehydrogenase inhibitors
|
|
US20100056600A1
(en)
*
|
2007-03-28 |
2010-03-04 |
Soren Ebdrup |
11beta-hsd1 active compounds
|
|
CN101677562A
(zh)
*
|
2007-04-11 |
2010-03-24 |
高点制药有限责任公司 |
新化合物
|
|
ES2393230T3
(es)
*
|
2007-04-24 |
2012-12-19 |
High Point Pharmaceuticals, Llc |
Uso farmacéutico de amidas sustituidas
|
|
GB0708186D0
(en)
*
|
2007-04-27 |
2007-06-06 |
Merck Sharp & Dohme |
Therapeutic compounds
|
|
ES2535317T3
(es)
|
2007-05-18 |
2015-05-08 |
Shionogi & Co., Ltd. |
Derivado heterocíclico que contiene nitrógeno que tiene actividad inhibidora de la 11 beta-hidroxiesteroide deshidrogenasa de tipo 1
|
|
AU2008259841B2
(en)
|
2007-05-31 |
2015-02-05 |
Sunovion Pharmaceuticals Inc. |
Phenyl substituted cycloalkylamines as monoamine reuptake inhibitors
|
|
EP1997805A1
(en)
*
|
2007-06-01 |
2008-12-03 |
Commissariat à l'Energie Atomique |
Compounds with antiparasitic activity, applications thereof to the treatment of infectious diseases caused by apicomplexans
|
|
CL2008001839A1
(es)
|
2007-06-21 |
2009-01-16 |
Incyte Holdings Corp |
Compuestos derivados de 2,7-diazaespirociclos, inhibidores de 11-beta hidroxil esteroide deshidrogenasa tipo 1; composicion farmaceutica que comprende a dichos compuestos; utiles para tratar la obesidad, diabetes, intolerancia a la glucosa, diabetes tipo ii, entre otras enfermedades.
|
|
ES2423181T3
(es)
*
|
2007-07-17 |
2013-09-18 |
F. Hoffmann-La Roche Ag |
Inhibidores de la 11ß-hidroxiesteroide-deshidrogenasa
|
|
JP5470557B2
(ja)
|
2007-07-26 |
2014-04-16 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１型の阻害剤の合成
|
|
CA2695437A1
(en)
|
2007-08-06 |
2009-02-12 |
Yoshihiro Horiuchi |
Aminopyrazole amide derivative
|
|
EP2025674A1
(de)
|
2007-08-15 |
2009-02-18 |
sanofi-aventis |
Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
JP5736098B2
(ja)
|
2007-08-21 |
2015-06-17 |
アッヴィ・インコーポレイテッド |
中枢神経系障害を治療するための医薬組成物
|
|
KR20100050444A
(ko)
|
2007-08-31 |
2010-05-13 |
아스텔라스세이야쿠 가부시키가이샤 |
피페리딘 유도체
|
|
US8119658B2
(en)
|
2007-10-01 |
2012-02-21 |
Bristol-Myers Squibb Company |
Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
|
|
WO2009056881A1
(en)
*
|
2007-10-29 |
2009-05-07 |
Astrazeneca Ab |
Chemical compounds 313
|
|
CN101909621A
(zh)
*
|
2007-11-06 |
2010-12-08 |
阿斯利康(瑞典)有限公司 |
4-[4-(2-金刚烷基氨基甲酰基)-5-叔丁基-吡唑-1-基]苯甲酸-465
|
|
AR069207A1
(es)
|
2007-11-07 |
2010-01-06 |
Vitae Pharmaceuticals Inc |
Ureas ciclicas como inhibidores de la 11 beta - hidroxi-esteroide deshidrogenasa 1
|
|
TW200927115A
(en)
|
2007-11-16 |
2009-07-01 |
Boehringer Ingelheim Int |
Aryl-and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use
|
|
ES2322121B1
(es)
*
|
2007-12-10 |
2010-04-19 |
Consejo Superior De Investigaciones Cientificas |
Nuevos derivados de aminoacidos dicarboxilicos y su aplicacion en el tratamiento de enfermedades neurodegenerativas.
|
|
US8440658B2
(en)
|
2007-12-11 |
2013-05-14 |
Vitae Pharmaceuticals, Inc. |
Cyclic urea inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
TW200934490A
(en)
|
2008-01-07 |
2009-08-16 |
Vitae Pharmaceuticals Inc |
Lactam inhibitors of 11 &abgr;-hydroxysteroid dehydrogenase 1
|
|
WO2009094169A1
(en)
|
2008-01-24 |
2009-07-30 |
Vitae Pharmaceuticals, Inc. |
Cyclic carbazate and semicarbazide inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
AU2009211215B2
(en)
*
|
2008-02-04 |
2011-11-03 |
Astrazeneca Ab |
Novel crystalline forms of 4- [4- (2-adamantylcarbam0yl) -5-tert-butyl-pyrazol-1-yl] benzoic acid
|
|
US8598160B2
(en)
|
2008-02-15 |
2013-12-03 |
Vitae Pharmaceuticals, Inc. |
Cycloalkyl lactame derivatives as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
|
|
EP2257340A2
(en)
*
|
2008-04-04 |
2010-12-08 |
BioMarin IGA Limited |
Compounds for treating muscular dystrophy
|
|
UY31774A
(es)
*
|
2008-04-22 |
2009-12-14 |
Astrazeneca Ab |
Compuestos de 2-pirimidin-5- ilcarboxamida sustituidos
|
|
EP2291370B1
(en)
|
2008-05-01 |
2013-11-27 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
JP5696037B2
(ja)
|
2008-05-01 |
2015-04-08 |
ヴァイティー ファーマシューティカルズ，インコーポレイテッド |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状インヒビター
|
|
RU2531272C2
(ru)
|
2008-05-01 |
2014-10-20 |
Вайтаи Фармасьютиклз, Инк. |
Циклические ингибиторы 11бета-гидроксистероид-дегидрогеназы 1
|
|
AR071719A1
(es)
|
2008-05-13 |
2010-07-07 |
Boehringer Ingelheim Int |
Derivados aliciclicos de acido carboxilico de benzomorfanos y estructuras relacionadas, medicamentos que contienen dichos compuestos y su uso.procesos de obtencion
|
|
TWI465439B
(zh)
|
2008-07-03 |
2014-12-21 |
Astellas Pharma Inc |
三氮唑衍生物或其鹽
|
|
UY31968A
(es)
|
2008-07-09 |
2010-01-29 |
Sanofi Aventis |
Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
|
|
EP2349484A2
(en)
*
|
2008-07-15 |
2011-08-03 |
Novartis AG |
Heteroaryl derivatives as dgat1 inhibitors
|
|
NZ590495A
(en)
|
2008-07-25 |
2012-10-26 |
Vitae Pharmaceuticals Inc |
Dihydropyridin-phenyl-3-oxazinan-2-ones as inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
WO2010010157A2
(en)
|
2008-07-25 |
2010-01-28 |
Boehringer Ingelheim International Gmbh |
INHIBITORS OF 11beta-HYDROXYSTEROID DEHYDROGENASE 1
|
|
CA2735204C
(en)
*
|
2008-08-25 |
2017-06-20 |
Boehringer Ingelheim International Gmbh |
Aryl- and heteroarylcarbonyl derivatives of substituted nortropanes, medicaments containing such compounds and their use
|
|
AU2009287118B9
(en)
|
2008-09-01 |
2014-08-07 |
Merck Patent Gmbh |
Fused pyrrolidino-cyclopropane derivatives as selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors
|
|
AR073920A1
(es)
|
2008-10-23 |
2010-12-09 |
Boehringer Ingelheim Int |
Derivados urea de nortropanos sustituidos, medicamentos que contienen dichos compuestos , su uso en el tratamiento de enfermedades mediadas por la inhibicion de la enzima 11beta-hidroxiesteroide deshidrogenasa y proceso para su preparacion.
|
|
US8927549B2
(en)
|
2008-11-21 |
2015-01-06 |
High Point Pharmaceuticals, Llc |
Adamantyl benzamide derivatives
|
|
WO2010068601A1
(en)
|
2008-12-08 |
2010-06-17 |
Sanofi-Aventis |
A crystalline heteroaromatic fluoroglycoside hydrate, processes for making, methods of use and pharmaceutical compositions thereof
|
|
TW201028421A
(en)
|
2009-01-15 |
2010-08-01 |
Abbott Lab |
Novel benzenesulfonamides as calcium channel blockers
|
|
CN102300851A
(zh)
*
|
2009-01-30 |
2011-12-28 |
阿斯利康(瑞典)有限公司 |
制备含羧基的吡唑酰氨基化合物597的新方法
|
|
JP5679997B2
(ja)
|
2009-02-04 |
2015-03-04 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
１１β−ヒドロキシステロイドデヒドロゲナーゼ１の環状阻害剤
|
|
US20120121515A1
(en)
|
2009-03-13 |
2012-05-17 |
Lenny Dang |
Methods and compositions for cell-proliferation-related disorders
|
|
US8569512B2
(en)
*
|
2009-03-23 |
2013-10-29 |
Merck Sharp & Dohme Corp. |
P2X3 receptor antagonists for treatment of pain
|
|
CA2758071C
(en)
|
2009-04-06 |
2018-01-09 |
Agios Pharmaceuticals, Inc. |
Pyruvate kinase m2 modulators, therapeutic compositions and related methods of use
|
|
US8680093B2
(en)
|
2009-04-30 |
2014-03-25 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1
|
|
US8703765B2
(en)
|
2009-06-02 |
2014-04-22 |
Boehringer Ingelheim International Gmbh |
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1
|
|
ES2350077B1
(es)
|
2009-06-04 |
2011-11-04 |
Laboratorios Salvat, S.A. |
Compuestos inhibidores de 11beta-hidroxiesteroide deshidrogenasa de tipo 1.
|
|
US8927539B2
(en)
|
2009-06-11 |
2015-01-06 |
Vitae Pharmaceuticals, Inc. |
Cyclic inhibitors of 11β-hydroxysteroid dehydrogenase 1 based on the 1,3-oxazinan-2-one structure
|
|
TWI598337B
(zh)
|
2009-06-29 |
2017-09-11 |
阿吉歐斯製藥公司 |
治療化合物及組成物
|
|
KR20120060207A
(ko)
|
2009-08-26 |
2012-06-11 |
사노피 |
신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도
|
|
US8642621B2
(en)
*
|
2009-09-16 |
2014-02-04 |
The University Of Edinburgh |
(4-phenyl-piperidin-1-yl)-[5-(1H-pyrazol-4-yl)-thiophen-3-yl]-methanone compounds and their use
|
|
TW201118085A
(en)
*
|
2009-10-20 |
2011-06-01 |
Astrazeneca Ab |
Adamantyl iminocarbonyl-substituted pyrimidines as inhibitors of 11-β-HSD1
|
|
WO2011050210A1
(en)
|
2009-10-21 |
2011-04-28 |
Agios Pharmaceuticals, Inc. |
Methods and compositions for cell-proliferation-related disorders
|
|
AR078887A1
(es)
|
2009-11-06 |
2011-12-07 |
Boehringer Ingelheim Int |
Derivados arilo y heteroarilcarbonilo de hexahidroindenopiridina y octahidrobenzoquinolina y composiciones farmaceuticas que los contienen.
|
|
ES2907862T3
(es)
*
|
2009-12-10 |
2022-04-26 |
Univ Columbia |
Activadores de histona acetiltransferasa y usos de los mismos
|
|
US10640457B2
(en)
|
2009-12-10 |
2020-05-05 |
The Trustees Of Columbia University In The City Of New York |
Histone acetyltransferase activators and uses thereof
|
|
WO2011099502A1
(ja)
*
|
2010-02-10 |
2011-08-18 |
公立大学法人横浜市立大学 |
神経選択的転写抑制因子NRSFに特異的に結合するmSin3B に結合する化合物の利用
|
|
WO2011107494A1
(de)
|
2010-03-03 |
2011-09-09 |
Sanofi |
Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2011112263A1
(en)
*
|
2010-03-11 |
2011-09-15 |
New York University |
AMIDO COMPOUNDS AS RORγt MODULATORS AND USES THEREOF
|
|
US8802868B2
(en)
|
2010-03-25 |
2014-08-12 |
Vertex Pharmaceuticals Incorporated |
Solid forms of (R)-1(2,2-difluorobenzo[D][1,3]dioxo1-5-yl)-N-(1-(2,3-dihydroxypropyl-6-fluoro-2-(1-hydroxy-2-methylpropan2-yl)-1H-Indol-5-yl)-Cyclopropanecarboxamide
|
|
ES2608474T3
(es)
|
2010-04-22 |
2017-04-11 |
Vertex Pharmaceuticals Incorporated |
Proceso de producción de compuestos indol cycloalkylcarboxamido
|
|
WO2011159760A1
(en)
|
2010-06-16 |
2011-12-22 |
Vitae Pharmaceuticals, Inc. |
Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their use
|
|
EP2582709B1
(de)
|
2010-06-18 |
2018-01-24 |
Sanofi |
Azolopyridin-3-on-derivate als inhibitoren von lipasen und phospholipasen
|
|
US8530413B2
(en)
|
2010-06-21 |
2013-09-10 |
Sanofi |
Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
|
|
EP2585054A1
(en)
|
2010-06-24 |
2013-05-01 |
Allergan, Inc. |
Derivatives of cycloalkyl- and cycloalkenyl-1,2-dicarboxylic acid compounds having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
|
|
WO2011161128A1
(en)
|
2010-06-25 |
2011-12-29 |
Boehringer Ingelheim International Gmbh |
Azaspirohexanones as inhibitors of 11-beta-hsd1 for the treatment of metabolic disorders
|
|
TW201215387A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Aventis |
Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
|
|
TW201221505A
(en)
|
2010-07-05 |
2012-06-01 |
Sanofi Sa |
Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
|
|
TW201215388A
(en)
|
2010-07-05 |
2012-04-16 |
Sanofi Sa |
(2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
|
|
AU2011202542A1
(en)
*
|
2010-07-14 |
2012-02-02 |
Indian Institute Of Science |
Benzothiophene carboxamide compounds, composition and applications thereof
|
|
FR2962649B1
(fr)
*
|
2010-07-19 |
2025-10-24 |
Conservatoire Nat Arts Et Metiers |
Traitement d'une pathologie liee a un effet excessif du tnf par un compose de benzene sulfonamide
|
|
WO2012015715A1
(en)
|
2010-07-27 |
2012-02-02 |
High Point Pharmaceuticals, Llc |
Substituted thiazol-2-ylamine derivatives, pharmaceutical compositions, and methods of use as 11-beta hsd1 modulators
|
|
UA112418C2
(uk)
|
2010-09-07 |
2016-09-12 |
Астеллас Фарма Інк. |
Терапевтичний болезаспокійливий засіб
|
|
WO2012059416A1
(en)
|
2010-11-02 |
2012-05-10 |
Boehringer Ingelheim International Gmbh |
Pharmaceutical combinations for the treatment of metabolic disorders
|
|
TWI537258B
(zh)
*
|
2010-11-05 |
2016-06-11 |
百靈佳殷格翰國際股份有限公司 |
六氫茚并吡啶及八氫苯并喹啉之芳基－及雜環芳基羰基衍生物
|
|
WO2012083246A1
(en)
|
2010-12-17 |
2012-06-21 |
Agios Pharmaceuticals, Inc. |
Novel n- (4- (azetidine - 1 - carbonyl) phenyl) - (hetero - ) arylsulfonamide derivatives as pyruvate kinase m2 (pmk2) modulators
|
|
ES2569712T3
(es)
|
2010-12-21 |
2016-05-12 |
Agios Pharmaceuticals, Inc. |
Activadores de PKM2 bicíclicos
|
|
EP2654428B1
(en)
|
2010-12-22 |
2018-02-14 |
The Trustees of Columbia University in the City of New York |
Histone acetyltransferase modulators and usese thereof
|
|
TWI549947B
(zh)
|
2010-12-29 |
2016-09-21 |
阿吉歐斯製藥公司 |
治療化合物及組成物
|
|
CN102584741A
(zh)
*
|
2011-01-06 |
2012-07-18 |
中国科学院上海药物研究所 |
酰胺类化合物及其制备方法、组合物和用途
|
|
EP2683704B1
(de)
|
2011-03-08 |
2014-12-17 |
Sanofi |
Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120058A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit benzyl- oder heteromethylengruppen substituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
WO2012120051A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Mit adamantan- oder noradamantan substituierte benzyl-oxathiazinderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
WO2012120056A1
(de)
|
2011-03-08 |
2012-09-13 |
Sanofi |
Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
EP2766349B1
(de)
|
2011-03-08 |
2016-06-01 |
Sanofi |
Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
US8828994B2
(en)
|
2011-03-08 |
2014-09-09 |
Sanofi |
Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
|
|
US8895547B2
(en)
|
2011-03-08 |
2014-11-25 |
Sanofi |
Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
|
|
EP2683702B1
(de)
|
2011-03-08 |
2014-12-24 |
Sanofi |
Neue substituierte phenyl-oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
|
|
EP2683699B1
(de)
|
2011-03-08 |
2015-06-24 |
Sanofi |
Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
|
|
KR101332805B1
(ko)
|
2011-03-31 |
2013-11-27 |
한국화학연구원 |
아다만틸기를 갖는 설파마이드 유도체 및 이의 약제학적으로 허용 가능한 염
|
|
CN102241678B
(zh)
*
|
2011-04-26 |
2014-10-29 |
辽宁利锋科技开发有限公司 |
含有脂环结构化合物的抗肿瘤作用与应用
|
|
CN104230935A
(zh)
*
|
2011-04-26 |
2014-12-24 |
辽宁利锋科技开发有限公司 |
含有脂环结构化合物的抗肿瘤作用与应用
|
|
SMT202400081T1
(it)
|
2011-05-03 |
2024-03-13 |
Agios Pharmaceuticals Inc |
Attivatori della piruvato chinasi per uso in terapia
|
|
CN103608016A
(zh)
|
2011-05-03 |
2014-02-26 |
安吉奥斯医药品有限公司 |
丙酮酸激酶激活剂在治疗中的用途
|
|
US9809532B2
(en)
|
2011-06-10 |
2017-11-07 |
The Trustees Of Columbia University In The City Of New York |
Uses of histone acetyltransferase activators
|
|
CN102827170A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
CN102827073A
(zh)
|
2011-06-17 |
2012-12-19 |
安吉奥斯医药品有限公司 |
治疗活性组合物和它们的使用方法
|
|
EP2739612B1
(en)
*
|
2011-08-01 |
2017-06-21 |
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd. |
Compounds and compositions for use in augmentation of glucose uptake and insulin secretion
|
|
WO2013025664A1
(en)
|
2011-08-17 |
2013-02-21 |
Boehringer Ingelheim International Gmbh |
Indenopyridine derivatives
|
|
SG11201400456RA
(en)
*
|
2011-09-09 |
2014-04-28 |
Univ New York |
Amido compounds as ror?tmodulators and uses thereof
|
|
WO2013037390A1
(en)
|
2011-09-12 |
2013-03-21 |
Sanofi |
6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
WO2013045413A1
(en)
|
2011-09-27 |
2013-04-04 |
Sanofi |
6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
|
|
KR101987514B1
(ko)
|
2011-10-18 |
2019-06-10 |
아스텔라스세이야쿠 가부시키가이샤 |
이환식 헤테로환 화합물
|
|
RU2672468C1
(ru)
*
|
2011-12-22 |
2018-11-15 |
Конекшис Лайф Сайенсиз Пвт. Лтд. |
Производные аза-адамантанов и их применение
|
|
SG11201403268QA
(en)
*
|
2011-12-22 |
2014-07-30 |
Connexios Life Sciences Pvt Ltd |
Cyclic amide derivatives as inhibitors of 11 - beta - hydroxysteroid dehydrogenase and uses thereof
|
|
US9474779B2
(en)
|
2012-01-19 |
2016-10-25 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compositions and their methods of use
|
|
WO2013146437A1
(ja)
*
|
2012-03-26 |
2013-10-03 |
シーシーアイ株式会社 |
３－デセン酸誘導体およびその用途
|
|
US8889730B2
(en)
|
2012-04-10 |
2014-11-18 |
Pfizer Inc. |
Indole and indazole compounds that activate AMPK
|
|
JP2015129094A
(ja)
*
|
2012-04-16 |
2015-07-16 |
大日本住友製薬株式会社 |
アリールアミノピラゾール誘導体
|
|
JOP20130213B1
(ar)
|
2012-07-17 |
2021-08-17 |
Takeda Pharmaceuticals Co |
معارضات لمستقبلht3-5
|
|
US10092574B2
(en)
|
2012-09-26 |
2018-10-09 |
Valorisation-Recherche, Limited Partnership |
Inhibitors of polynucleotide repeat-associated RNA foci and uses thereof
|
|
GB201218084D0
(en)
*
|
2012-10-09 |
2012-11-21 |
Univ Aston |
Novel compounds and methods for use in medicine
|
|
WO2014074976A1
(en)
*
|
2012-11-09 |
2014-05-15 |
Musc Foundation For Research Development |
Compositions and methods for treating neurological diseases or injury
|
|
MX352873B
(es)
|
2013-03-13 |
2017-12-13 |
Unilever Nv |
Composiciones fotoprotectoras con triciclodecano amidas.
|
|
CA2902494C
(en)
|
2013-03-13 |
2021-01-26 |
Unilever Plc |
Prolonged delivery of certain fragrance components from personal care compositions
|
|
CA2902333C
(en)
|
2013-03-13 |
2021-06-08 |
Unilever Plc |
Cosmetic compositions with tricyclodecane amides
|
|
EP2970177A1
(en)
|
2013-03-15 |
2016-01-20 |
Pfizer Inc. |
Indole compounds that activate ampk
|
|
WO2014139144A1
(en)
*
|
2013-03-15 |
2014-09-18 |
Agios Pharmaceuticals, Inc. |
Therapeutic compounds and compositions
|
|
WO2015003360A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
WO2015003355A2
(en)
|
2013-07-11 |
2015-01-15 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
CN105593215B
(zh)
|
2013-07-11 |
2019-01-15 |
安吉奥斯医药品有限公司 |
用于治疗癌症的作为idh2突变体抑制剂的2,4-或4,6-二氨基嘧啶化合物
|
|
WO2015010297A1
(en)
|
2013-07-25 |
2015-01-29 |
Agios Pharmaceuticals, Inc. |
Therapeutically active compounds and their methods of use
|
|
GB201317363D0
(en)
|
2013-10-01 |
2013-11-13 |
Eisai Ltd |
Novel compounds
|
|
NZ723859A
(en)
|
2014-03-14 |
2023-01-27 |
Servier Lab |
Pharmaceutical compositions of therapeutically active compounds and their uses
|
|
WO2015153410A1
(en)
*
|
2014-03-31 |
2015-10-08 |
The Trustees Of Columbia University In The City Of New York |
Histone acetyltransferase activators and uses thereof
|
|
ES2885181T3
(es)
|
2014-04-15 |
2021-12-13 |
Vertex Pharma |
Composiciones farmacéuticas para el tratamiento de enfermedades mediadas por el regulador de la conductancia transmembrana de fibrosis quística
|
|
PE20170518A1
(es)
|
2014-06-16 |
2017-04-30 |
Univ Lille Ii Droit & Sante |
Compuestos, composicion farmaceutica y su uso en el tratamiento de enfermedades neurodegenerativas
|
|
CA2962429C
(en)
|
2014-09-29 |
2023-01-03 |
Takeda Pharmaceutical Company Limited |
Crystalline form of 1-(1-methyl-1h-pyrazol-4-yl)-n-((1r,5s,7s)-9-methyl-3-oxa-9-azabicyclo[3.3.1]nonan-7-yl)-1h-indole-3-carboxamide
|
|
TWI874834B
(zh)
|
2014-12-18 |
2025-03-01 |
瑞士商赫孚孟拉羅股份公司 |
四氫-吡啶并[3,4-b]吲哚雌激素受體調節劑及其用途
|
|
CA2989111C
(en)
|
2015-06-11 |
2023-10-03 |
Agios Pharmaceuticals, Inc. |
Methods of using pyruvate kinase activators
|
|
FI3362065T3
(fi)
|
2015-10-15 |
2024-06-19 |
Servier Lab |
Ivosidenibiä, sytarabiinia ja daunorubisiinia tai idarubisiinia käsittävä yhdistelmähoito akuutin myelooisen leukemian hoitamiseksi
|
|
KR102699521B1
(ko)
|
2015-10-15 |
2024-08-26 |
르 라보레또레 쎄르비에르 |
악성 종양의 치료를 위한 조합물 요법
|
|
US11872207B2
(en)
|
2015-12-24 |
2024-01-16 |
Mcmaster University |
Dronedarone and derivatives thereof for treating cancer
|
|
US10576056B2
(en)
|
2015-12-24 |
2020-03-03 |
Mcmaster University |
Compounds for treating cancer and methods of use thereof
|
|
CA3010615C
(en)
|
2016-01-14 |
2024-02-20 |
Beth Israel Deaconess Medical Center, Inc. |
Mast-cell modulators and uses thereof
|
|
WO2017205622A1
(en)
*
|
2016-05-25 |
2017-11-30 |
Savant Neglected Diseases, Llc |
Method of making benznidazole
|
|
AR108586A1
(es)
*
|
2016-06-10 |
2018-09-05 |
Lilly Co Eli |
Compuestos de 2,3-dihidro-1h-indol
|
|
JP7097828B2
(ja)
|
2016-06-21 |
2022-07-08 |
シファ バイオメディカル コーポレーション |
抗プロタンパク質変換酵素サブチリシン ケキシン タイプ９（Ｓｕｂｔｉｌｉｓｉｎ Ｋｅｘｉｎ Ｔｙｐｅ ９）（抗ＰＣＳＫ９）化合物および心血管疾患の治療および／または予防にこれを使用する方法
|
|
CN107663159A
(zh)
*
|
2016-07-29 |
2018-02-06 |
上海迪诺医药科技有限公司 |
多环化合物、其药物组合物及应用
|
|
JP2020514323A
(ja)
*
|
2017-02-06 |
2020-05-21 |
ケース ウエスタン リザーブ ユニバーシティ |
短鎖デヒドロゲナーゼ活性を調節する組成物と方法
|
|
EP3375778A1
(en)
*
|
2017-03-14 |
2018-09-19 |
Artax Biopharma Inc. |
Aryl-piperidine derivatives
|
|
LT3483164T
(lt)
|
2017-03-20 |
2020-05-11 |
Forma Therapeutics, Inc. |
Pirolpirolo kompozicijos kaip piruvato kinazės (pkr) aktyvatoriai
|
|
US10980788B2
(en)
|
2018-06-08 |
2021-04-20 |
Agios Pharmaceuticals, Inc. |
Therapy for treating malignancies
|
|
CR20200621A
(es)
|
2018-06-21 |
2021-02-03 |
Hoffmann La Roche |
Formas sólidas de 3-((1r,3r)-1-(2,6-difluoro-4-((1-(3 fluoropropil)azetidin-3-il)amino)fenil)-3-(metil-1,3,4,9-tetrahidro-2h-pirido[3,4-b]indol-2-il)-2,2-difluoropropan-1-ol y procesos para preparar compuestos tricíclicos fusionados que comprenden un resto fenilo o piridinilo sustituido, incluidos métodos para su uso
|
|
AU2019318209B2
(en)
|
2018-08-10 |
2025-09-25 |
Diapin Therapeutics, Llc |
Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders
|
|
EP3853206B1
(en)
|
2018-09-19 |
2024-04-10 |
Novo Nordisk Health Care AG |
Treating sickle cell disease with a pyruvate kinase r activating compound
|
|
EP3852791B1
(en)
|
2018-09-19 |
2024-07-03 |
Novo Nordisk Health Care AG |
Activating pyruvate kinase r
|
|
CN109452280B
(zh)
|
2018-11-15 |
2021-01-29 |
南开大学 |
一种利用二氧化碳生产杀虫剂的工艺方法
|
|
AU2019384074B2
(en)
|
2018-11-20 |
2025-04-10 |
Sparrow Pharmaceuticals, Inc. |
Methods for administering corticosteroids
|
|
KR102921276B1
(ko)
|
2018-11-21 |
2026-02-03 |
케이스 웨스턴 리저브 유니버시티 |
단쇄 데히드로게나아제 활성을 조절하는 조성물 및 방법
|
|
US11174263B2
(en)
|
2018-12-31 |
2021-11-16 |
Biomea Fusion, Inc. |
Inhibitors of menin-MLL interaction
|
|
SG11202106304RA
(en)
|
2018-12-31 |
2021-07-29 |
Biomea Fusion Llc |
Irreversible inhibitors of menin-mll interaction
|
|
EP3960736A4
(en)
*
|
2019-04-26 |
2023-04-19 |
Generos Biopharma Ltd. |
HETEROCYCLIC COMPOUND, ITS APPLICATION AND COMPOSITION WITH IT
|
|
HRP20251148T1
(hr)
|
2019-09-19 |
2025-11-21 |
Novo Nordisk Health Care Ag |
Pripravci koji aktiviraju piruvat-kinazu r (pkr)
|
|
CN112812077B
(zh)
*
|
2019-11-18 |
2023-08-22 |
中国科学院上海药物研究所 |
苯甲酰胺类化合物及其制备方法、药物组合物和用途
|
|
KR20220146458A
(ko)
*
|
2020-01-23 |
2022-11-01 |
마이오포르테 테라퓨틱스 인코포레이티드 |
Pgdh 억제제 및 그의 제조 및 사용 방법
|
|
WO2022036104A1
(en)
*
|
2020-08-12 |
2022-02-17 |
University Of Iowa Research Foundation |
Insulin sensitizers for the treatment of diabetes mellitus
|
|
US12128035B2
(en)
|
2021-03-19 |
2024-10-29 |
Novo Nordisk Health Care Ag |
Activating pyruvate kinase R
|
|
TW202320796A
(zh)
|
2021-08-11 |
2023-06-01 |
美商拜歐米富士恩股份有限公司 |
用於糖尿病的menin-mll相互作用之共價抑制劑
|
|
US12018032B2
(en)
|
2021-08-20 |
2024-06-25 |
Biomea Fusion, Inc. |
Crystalline forms of N-[4-[4-(4-morpholinyl)-7H-pyrrolo[2,3-d]pyrimidin-6-yl]phenyl]-4-[[3(r)-[(1-oxo-2-propen-1-yl)amino]-1-piperidinyl]methyl]-2-pyridinecarboxamide as an irreversible inhibitor of menin-MLL interaction
|
|
EP4525983A4
(en)
|
2022-05-16 |
2025-09-03 |
Sparrow Pharmaceuticals Inc |
METHODS AND COMPOSITIONS FOR TREATING GLUCOCORTICOID EXCESS
|
|
WO2024155710A1
(en)
|
2023-01-18 |
2024-07-25 |
Biomea Fusion, Inc. |
Crystalline forms of n-[4-[4-(4-morpholinyl)-7h-pyrrolo[2,3-d]pyrimidin-6- yl]phenyl]-4-[[3(r)-[(l-oxo-2-propen-l-yl)amino]-l-piperidinyl]methyl]-2-pyridinecarboxamide as a covalent inhibitor of menin-mll interaction
|